Cargando…

Inhalatives Budesonid zur Therapie bei COVID-19

Detalles Bibliográficos
Autores principales: Kluge, S., Nitschmann, S., Scherer, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Medizin 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8242272/
https://www.ncbi.nlm.nih.gov/pubmed/34191054
http://dx.doi.org/10.1007/s00108-021-01071-4
_version_ 1783715598502461440
author Kluge, S.
Nitschmann, S.
Scherer, M.
author_facet Kluge, S.
Nitschmann, S.
Scherer, M.
author_sort Kluge, S.
collection PubMed
description
format Online
Article
Text
id pubmed-8242272
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Medizin
record_format MEDLINE/PubMed
spelling pubmed-82422722021-07-01 Inhalatives Budesonid zur Therapie bei COVID-19 Kluge, S. Nitschmann, S. Scherer, M. Internist (Berl) Klinische Studien Springer Medizin 2021-06-30 2021 /pmc/articles/PMC8242272/ /pubmed/34191054 http://dx.doi.org/10.1007/s00108-021-01071-4 Text en © Springer Medizin Verlag GmbH, ein Teil von Springer Nature 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Klinische Studien
Kluge, S.
Nitschmann, S.
Scherer, M.
Inhalatives Budesonid zur Therapie bei COVID-19
title Inhalatives Budesonid zur Therapie bei COVID-19
title_full Inhalatives Budesonid zur Therapie bei COVID-19
title_fullStr Inhalatives Budesonid zur Therapie bei COVID-19
title_full_unstemmed Inhalatives Budesonid zur Therapie bei COVID-19
title_short Inhalatives Budesonid zur Therapie bei COVID-19
title_sort inhalatives budesonid zur therapie bei covid-19
topic Klinische Studien
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8242272/
https://www.ncbi.nlm.nih.gov/pubmed/34191054
http://dx.doi.org/10.1007/s00108-021-01071-4
work_keys_str_mv AT kluges inhalativesbudesonidzurtherapiebeicovid19
AT nitschmanns inhalativesbudesonidzurtherapiebeicovid19
AT schererm inhalativesbudesonidzurtherapiebeicovid19